51 Stocks Moving In Tuesday's Mid-Day Session

Gainers

• Alterity Therapeutics Limited ATHE shares jumped 118% to $1.2750 after the company said that following a pre-IND meeting regarding its lead drug candidate ATH434 for the treatment of multiple system atrophy, a Parkinsonian disorder, it has reached an agreement with the FDA on the non-clinical investigations required to support the Phase 2 study..
• Polar Power, Inc. POLA shares jumped 100.7% to $2.7490 after jumping around 9% on Monday.
• Blink Charging Co. BLNK shares gained 56.6% to $6.28 after gaining 33% on Monday.
• Carver Bancorp, Inc. CARV shares gained 56.2% to $9.17.
• Qumu Corporation QUMU shares climbed 27.5% to $3.06. Synacor and Qumu reported mutual termination of merger deal.
• Workhorse Group Inc. WKHS gained 27% to $18.41 after the company secured $70 million in financing from institutional investors.
• Bloom Energy Corporation BE climbed 25.3% to $10.30. Bloom Energy and Samsung Heavy signed a joint development agreement to design and develop fuel cell-powered ships.
• Citi Trends, Inc. CTRN rose 25.3% to $19.93 after the company issued a business update. Its comparable sales in reopened stores climbed 53% in the second quarter through June 27, 2020.
• Anixa Biosciences, Inc. ANIX gained 22.6% to $3.58.
• Forterra, Inc. FRTA shares rose 20.8% to $11.28. Forterra sees preliminary Q2 sales of $410 million to $430 million and adjusted EBITDA of $77 million to $82 million.
• Calliditas Therapeutics AB CALT climbed 20.2% to $23.99 after Jefferies initiated coverage on the stock with a Buy rating and a price target of $44 per share.
• Vaxart, Inc. VXRT shares rose 19.6% to $8.96.
• Envision Solar International, Inc. EVSI shares jumped 18.4% to $10.37. Envision Solar deployed solar-powered EV DC fast charging for Shandon California rest area on the US Highway 46 East.
• Charah Solutions, Inc. CHRA climbed 17.6% to $3.01.
• ViewRay, Inc. VRAY shares gained 16.5% to $2.39.
• Kirkland's, Inc. KIRK shares rose 16.4% to $2.6433.
• NantKwest, Inc. NK climbed 16.2% to $12.57. NantKwest reported closing of $90.7 million public offering of common stock and full exercise of underwriters’ option to purchase additional shares.
• OptiNose, Inc. OPTN shares gained 15.7% to $7.43 after the company announced anti-COVID-19 product candidate.
• Himax Technologies, Inc. HIMX shares rose 15.3% to $3.76. Himax launched WiseEye WE-I Plus HX6537-A to 'support AI deep learning with Google's TensorFlow Lite for Microcontrollers.'
• GrowGeneration Corp. GRWG climbed 14% to $6.91 after the company reported pricing of $42 million upsized public offering of common stock.
• Applied Optoelectronics, Inc. AAOI shares rose 13.7% to $10.69.
• 9 Meters Biopharma, Inc. NMTR gained 12.2% to $0.6291 after SunTrust Robinson Humphrey initiated coverage on the stock with a Buy rating and a price target of $5 per share.
• Farmmi, Inc. FAMI rose 8.7% to $0.69 after the company’s subsidiary received multiple repeat orders for distribution in the US and Israel.
• Landcadia Holdings II, Inc. LCA rose 8.3% to $15.60. Landcadia shares jumped 43% on Monday after the special purpose acquisition company acquired Golden Nugget Online Gaming.
• Acuity Brands, Inc. AYI gained 8% to $96.43 after reporting better-than-expected Q3 results.
• Hepion Pharmaceuticals, Inc. HEPA shares rose 7.4% to $2.91 after the company reported the advancement to the final dose level in its ongoing clinical trial of CRV431.
• Xilinx, Inc. XLNX rose 7.3% to $98.64 after the company raised its revenue forecast for the first quarter.
• Broadwind, Inc. BWEN rose 6.5% to $3.75.
• Micron Technology, Inc. MU rose 6.4% to $52.28 after the company reported better-than-expected results for its third quarter and issued a strong forecast for the current quarter.
• Tesla, Inc. TSLA gained 5.9% to $1,068.79 following reports of a leaked e-mail from Elon Musk suggesting the company could break even in Q2.

Check out these big penny stock gainers and losers

Losers

• Zynerba Pharmaceuticals, Inc. ZYNE fell 48% to $3.40. Announcing top line results from the 14-week pivotal CONNECT-FX study that is evaluating its Zygel in Fragile X syndrome patients, Zynerba Pharmaceuticals said Zygel did not achieve statistical significance versus placebo in the primary endpoint as well as the three key secondary endpoints.
• OncoCyte Corporation OCX shares dipped 42.1% to $1.87 after the company said following the completion of the Clinical Validation study of DetermaDx, its liquid biopsy test intended to clarify whether a lung nodule is suspicious or likely benign, demonstrated that the performance of DetermaDx did not meet the predetermined endpoints for the study. Chardan Capital downgraded OncoCyte from Buy to Neutral and lowered the price target from $7.75 to $2.
• Verrica Pharmaceuticals Inc. VRCA fell 25.6% to $10.47 after the company said it has received a letter from the FDA regarding the NDA for VP-102, its lead drug candidate for the treatment of molluscum contagiosum, stating there are deficiencies in the application that ruled out discussion of labeling and post-marketing requirements/commitments at this time.
• PDS Biotechnology Corporation PDSB fell 23.8% to $1.98 after climbing more than 60% on Monday.
• Genworth Financial, Inc. GNW shares dropped 23.7% to $1.9521 after the company reported merger agreement extension to September 30.
• CleanSpark, Inc. CLSK shares declined 19.7% to $2.61.
• Liquidia Technologies Inc LQDA fell 19.3% to $8.60. Liquidia priced its 9.375 million share offering at $8 per share.
• Landec Corporation LNDC dipped 18.4% to $8.00. Landec sees preliminary Q4 adjusted earnings of $0.01 to $0.06 per share on sales of $156.1 million.
• Fuel Tech, Inc. FTEK fell 15.3% to $0.8899 after rising around 39% on Monday.
• Seanergy Maritime Holdings Corp. SHIP dropped 15.1% to $2.14.
• Molecular Data Inc. MKD shares declined 14.8% to $2.41. Molecular Data filed 2019 annual report on Form 20-F.
• Enlivex Therapeutics Ltd. ENLV shares tumbled 14.3% to $5.21.
• Contango Oil & Gas Company MCF dropped 13.8% to $2.2850.
• Energy Recovery, Inc. ERII shares fell 13.4% to $7.72 after the company reported exit from VorTeq exclusive licensing agreement with Schlumberger. B. Riley FBR downgraded Energy Recovery from Buy to Neutral.
• Puhui Wealth Investment Management Co., Ltd. PHCF fell 13.4% to $7.00 following a 50% surge on Monday.
• Trinity Biotech plc TRIB shares declined 12.7% to $2.14.
• Boxlight Corporation BOXL fell 11.1% to $0.9420 after gaining more than 32% on Monday.
• Inovio Pharmaceuticals Inc INO dropped 10.7% to $28.33 after the company reported Phase 1 data for its INO-4800 coronavirus vaccine candidate, which showed a 94% response rate.
• Iterum Therapeutics plc ITRM fell 9.9% to $1.28. Iterum Therapeutics shares fell over 7% on Monday after the company reported topline results from Phase 3 clinical trial of oral sulopenem for the treatment of uncomplicated urinary tract infections.
• Ebang International Holdings Inc. EBON fell 6.4% to $4.21 after declining 10% on Monday.
• Crispr Therapeutics AG CRSP shares fell 5% to $71.42 after reporting a $325 million common stock offering.